---
name: modeling-counterparty-credit-exposure-7a8d3d3090f2
language: en
description: Calculates potential future exposure and CVA with simulation-based approaches and netting agreement analysis. Use when modeling counterparty exposure, calculating CVA/DVA, or assessing counterparty risk.
tags:
  - modeling
  - derivatives-and-structured-products
  - risk
metadata:
  author: casemark
  practice_areas:
    - Derivatives
    - Structured Products
    - Hedging
  document_types:
    - Financial Model
  skill_modes:
    - Modeling
    - Forecasting
---
# Modeling Counterparty Credit Exposure

## When To Use

- Calculating potential future exposure (PFE) profiles for OTC derivative portfolios
- Computing credit valuation adjustment (CVA) and debit valuation adjustment (DVA) for pricing or accounting (ASC 820 / IFRS 13)
- Assessing counterparty credit limits and concentration risk across netting sets
- Evaluating the impact of collateral agreements (CSAs) on exposure profiles
- Stress-testing counterparty exposure under adverse market scenarios
- Supporting regulatory capital calculations under SA-CCR or IMM [VERIFY: applicable regulatory framework]

## Inputs To Gather

- **Trade population**: Full list of trades per counterparty, including notional, trade date, maturity, currency, and product type (IRS, CDS, FX forwards, equity options, etc.)
- **Netting agreements**: ISDA Master Agreement status, netting set definitions, and any close-out netting enforceability opinions [VERIFY: jurisdiction-specific enforceability]
- **Collateral terms**: CSA parameters — threshold, minimum transfer amount (MTA), independent amount, eligible collateral types, rehypothecation rights, margin period of risk (MPR)
- **Market data**: Yield curves, volatility surfaces, FX spot rates, credit spreads (CDS or bond-implied), correlation assumptions
- **Counterparty credit data**: Credit ratings, CDS spreads (or proxy spreads), probability of default (PD) term structures, loss given default (LGD) assumptions
- **Own credit data**: Entity CDS spreads or proxy for DVA calculation
- **Simulation parameters**: Number of Monte Carlo paths, time grid granularity, confidence level for PFE (typically 95th or 97.5th percentile), simulation horizon

## Workflow

1. **Map netting sets and collateral**
   - Group trades by legal netting agreement; confirm enforceability per jurisdiction
   - Parse CSA terms: thresholds, MTAs, MPR, eligible collateral haircuts
   - Identify wrong-way risk exposures (counterparty credit quality correlated with exposure)

2. **Calibrate market models**
   - Select diffusion processes per risk factor (e.g., Hull-White for rates, GBM or local vol for equities/FX, reduced-form for credit)
   - Calibrate to current market data; document calibration targets and fit quality
   - Set correlation matrix across risk factors — use historical estimation with appropriate lookback window

3. **Run Monte Carlo simulation**
   - Simulate joint evolution of all risk factors across the time grid
   - Reprice each trade at each time step on each path (use analytic approximations or regression-based methods like Longstaff-Schwartz for early-exercise products)
   - Aggregate to netting-set level, apply close-out netting: net exposure = max(0, sum of MTMs within netting set)

4. **Apply collateral dynamics**
   - Model collateral calls with MPR lag (typically 10–20 business days for bilateral, 5 for cleared)
   - Apply thresholds, MTAs, and independent amounts per CSA
   - Compute collateralized exposure at each time step: E(t) = max(0, net MTM − collateral held)

5. **Calculate exposure metrics**
   - **Expected Exposure (EE)**: Mean of positive exposures across paths at each time step
   - **Potential Future Exposure (PFE)**: Quantile of exposure distribution (95th/97.5th percentile) at each time step
   - **Expected Positive Exposure (EPE)**: Time-weighted average of EE over the profile
   - **Peak PFE**: Maximum PFE across the time grid
   - **Effective EPE**: Non-decreasing transformation of EPE for regulatory purposes

6. **Compute CVA and DVA**
   - CVA = integral of discounted EE × counterparty default probability × LGD over the exposure horizon
   - DVA = integral of discounted ENE (expected negative exposure) × own default probability × LGD
   - Use counterparty CDS spreads for market-implied PD; use rating-based PD for accounting if required [VERIFY: CVA methodology — market-implied vs. historical PD per firm policy]
   - Consider bilateral CVA (BCVA = CVA − DVA) and FVA if required

7. **Stress test and validate**
   - Run exposure profiles under stressed market scenarios (rate shocks, spread widening, FX moves)
   - Test sensitivity to correlation assumptions, number of simulation paths, and time-grid density
   - Compare model PFE against add-on based methods (SA-CCR) as a reasonableness check
   - Back-test exposure predictions against realized MTMs where historical data is available

## Output

- **Exposure profile report**: Time-series charts of EE, PFE (with confidence level), and peak PFE per netting set and counterparty
- **CVA/DVA summary**: Unilateral CVA, DVA, and bilateral CVA per counterparty with breakdown by netting set
- **Collateral impact analysis**: Comparison of uncollateralized vs. collateralized exposure profiles showing CSA benefit
- **Sensitivity tables**: CVA sensitivity to credit spread moves (CS01), interest rate shifts, and correlation changes
- **Wrong-way risk flags**: Identification of netting sets where exposure and counterparty default are positively correlated
- **Methodology documentation**: Model choices, calibration details, simulation parameters, and all assumptions

## Quality Checks

- Verify that netting-set groupings match legal documentation — incorrect netting inflates or deflates exposure
- Confirm collateral parameters (thresholds, MTA, MPR) are sourced from actual CSA terms, not defaults
- Check that the number of Monte Carlo paths produces stable results (re-run with doubled paths; PFE should not shift materially)
- Validate that EE converges to zero as trades approach maturity
- Ensure PFE at the 95th percentile exceeds EE at every time step — if not, check for simulation errors
- Cross-check CVA magnitude against market benchmarks: CVA as basis points of notional should be plausible given counterparty spread level
- Confirm discount curves and credit curves are as-of the same valuation date
- Flag any trades with missing market data or valuation failures — do not silently drop them from the simulation
- Mark all jurisdiction-dependent assumptions (netting enforceability, MPR regulatory minimums, capital framework) with [VERIFY]


---
Source attribution: CaseMark
Original project: https://github.com/CaseMark/skills/blob/449269ec49b6a8f1b4614cea52aa44b2a76e4e94/skills/capital/modeling-counterparty-credit-exposure/SKILL.md
License: Apache-2.0
License information: https://www.apache.org/licenses/LICENSE-2.0
Original upstream instructions; downloaded from Mega AI Hub.

## Upstream license notice

                                 Apache License
                           Version 2.0, January 2004
                        http://www.apache.org/licenses/

   TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION

   1. Definitions.

      "License" shall mean the terms and conditions for use, reproduction,
      and distribution as defined by Sections 1 through 9 of this document.

      "Licensor" shall mean the copyright owner or entity authorized by
      the copyright owner that is granting the License.

      "Legal Entity" shall mean the union of the acting entity and all
      other entities that control, are controlled by, or are under common
      control with that entity. For the purposes of this definition,
      "control" means (i) the power, direct or indirect, to cause the
      direction or management of such entity, whether by contract or
      otherwise, or (ii) ownership of fifty percent (50%) or more of the
      outstanding shares, or (iii) beneficial ownership of such entity.

      "You" (or "Your") shall mean an individual or Legal Entity
      exercising permissions granted by this License.

      "Source" form shall mean the preferred form for making modifications,
      including but not limited to software source code, documentation
      source, and configuration files.

      "Object" form shall mean any form resulting from mechanical
      transformation or translation of a Source form, including but
      not limited to compiled object code, generated documentation,
      and conversions to other media types.

      "Work" shall mean the work of authorship, whether in Source or
      Object form, made available under the License, as indicated by a
      copyright notice that is included in or attached to the work
      (an example is provided in the Appendix below).

      "Derivative Works" shall mean any work, whether in Source or Object
      form, that is based on (or derived from) the Work and for which the
      editorial revisions, annotations, elaborations, or other modifications
      represent, as a whole, an original work of authorship. For the purposes
      of this License, Derivative Works shall not include works that remain
      separable from, or merely link (or bind by name) to the interfaces of,
      the Work and Derivative Works thereof.

      "Contribution" shall mean any work of authorship, including
      the original version of the Work and any modifications or additions
      to that Work or Derivative Works thereof, that is intentionally
      submitted to the Licensor for inclusion in the Work by the copyright owner
      or by an individual or Legal Entity authorized to submit on behalf of
      the copyright owner. For the purposes of this definition, "submitted"
      means any form of electronic, verbal, or written communication sent
      to the Licensor or its representatives, including but not limited to
      communication on electronic mailing lists, source code control systems,
      and issue tracking systems that are managed by, or on behalf of, the
      Licensor for the purpose of discussing and improving the Work, but
      excluding communication that is conspicuously marked or otherwise
      designated in writing by the copyright owner as "Not a Contribution."

      "Contributor" shall mean Licensor and any individual or Legal Entity
      on behalf of whom a Contribution has been received by the Licensor and
      subsequently incorporated within the Work.

   2. Grant of Copyright License. Subject to the terms and conditions of
      this License, each Contributor hereby grants to You a perpetual,
      worldwide, non-exclusive, no-charge, royalty-free, irrevocable
      copyright license to reproduce, prepare Derivative Works of,
      publicly display, publicly perform, sublicense, and distribute the
      Work and such Derivative Works in Source or Object form.

   3. Grant of Patent License. Subject to the terms and conditions of
      this License, each Contributor hereby grants to You a perpetual,
      worldwide, non-exclusive, no-charge, royalty-free, irrevocable
      (except as stated in this section) patent license to make, have made,
      use, offer to sell, sell, import, and otherwise transfer the Work,
      where such license applies only to those patent claims licensable
      by such Contributor that are necessarily infringed by their
      Contribution(s) alone or by combination of their Contribution(s)
      with the Work to which such Contribution(s) was submitted. If You
      institute patent litigation against any entity (including a
      cross-claim or counterclaim in a lawsuit) alleging that the Work
      or a Contribution incorporated within the Work constitutes direct
      or contributory patent infringement, then any patent licenses
      granted to You under this License for that Work shall terminate
      as of the date such litigation is filed.

   4. Redistribution. You may reproduce and distribute copies of the
      Work or Derivative Works thereof in any medium, with or without
      modifications, and in Source or Object form, provided that You
      meet the following conditions:

      (a) You must give any other recipients of the Work or
          Derivative Works a copy of this License; and

      (b) You must cause any modified files to carry prominent notices
          stating that You changed the files; and

      (c) You must retain, in the Source form of any Derivative Works
          that You distribute, all copyright, patent, trademark, and
          attribution notices from the Source form of the Work,
          excluding those notices that do not pertain to any part of
          the Derivative Works; and

      (d) If the Work includes a "NOTICE" text file as part of its
          distribution, then any Derivative Works that You distribute must
          include a readable copy of the attribution notices contained
          within such NOTICE file, excluding any notices that do not
          pertain to any part of the Derivative Works, in at least one
          of the following places: within a NOTICE text file distributed
          as part of the Derivative Works; within the Source form or
          documentation, if provided along with the Derivative Works; or,
          within a display generated by the Derivative Works, if and
          wherever such third-party notices normally appear. The contents
          of the NOTICE file are for informational purposes only and
          do not modify the License. You may add Your own attribution
          notices within Derivative Works that You distribute, alongside
          or as an addendum to the NOTICE text from the Work, provided
          that such additional attribution notices cannot be construed
          as modifying the License.

      You may add Your own copyright statement to Your modifications and
      may provide additional or different license terms and conditions
      for use, reproduction, or distribution of Your modifications, or
      for any such Derivative Works as a whole, provided Your use,
      reproduction, and distribution of the Work otherwise complies with
      the conditions stated in this License.

   5. Submission of Contributions. Unless You explicitly state otherwise,
      any Contribution intentionally submitted for inclusion in the Work
      by You to the Licensor shall be under the terms and conditions of
      this License, without any additional terms or conditions.
      Notwithstanding the above, nothing herein shall supersede or modify
      the terms of any separate license agreement you may have executed
      with Licensor regarding such Contributions.

   6. Trademarks. This License does not grant permission to use the trade
      names, trademarks, service marks, or product names of the Licensor,
      except as required for reasonable and customary use in describing the
      origin of the Work and reproducing the content of the NOTICE file.

   7. Disclaimer of Warranty. Unless required by applicable law or
      agreed to in writing, Licensor provides the Work (and each
      Contributor provides its Contributions) on an "AS IS" BASIS,
      WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or
      implied, including, without limitation, any warranties or conditions
      of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A
      PARTICULAR PURPOSE. You are solely responsible for determining the
      appropriateness of using or redistributing the Work and assume any
      risks associated with Your exercise of permissions under this License.

   8. Limitation of Liability. In no event and under no legal theory,
      whether in tort (including negligence), contract, or otherwise,
      unless required by applicable law (such as deliberate and grossly
      negligent acts) or agreed to in writing, shall any Contributor be
      liable to You for damages, including any direct, indirect, special,
      incidental, or consequential damages of any character arising as a
      result of this License or out of the use or inability to use the
      Work (including but not limited to damages for loss of goodwill,
      work stoppage, computer failure or malfunction, or any and all
      other commercial damages or losses), even if such Contributor
      has been advised of the possibility of such damages.

   9. Accepting Warranty or Additional Liability. While redistributing
      the Work or Derivative Works thereof, You may choose to offer,
      and charge a fee for, acceptance of support, warranty, indemnity,
      or other liability obligations and/or rights consistent with this
      License. However, in accepting such obligations, You may act only
      on Your own behalf and on Your sole responsibility, not on behalf
      of any other Contributor, and only if You agree to indemnify,
      defend, and hold each Contributor harmless for any liability
      incurred by, or claims asserted against, such Contributor by reason
      of your accepting any such warranty or additional liability.

   END OF TERMS AND CONDITIONS

   Copyright 2025 CaseMark, Inc.

   Licensed under the Apache License, Version 2.0 (the "License");
   you may not use this file except in compliance with the License.
   You may obtain a copy of the License at

       http://www.apache.org/licenses/LICENSE-2.0

   Unless required by applicable law or agreed to in writing, software
   distributed under the License is distributed on an "AS IS" BASIS,
   WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
   See the License for the specific language governing permissions and
   limitations under the License.



# Mega AI Hub resource metadata

Creator / publisher: CaseMark
Original project: https://github.com/CaseMark/skills/blob/449269ec49b6a8f1b4614cea52aa44b2a76e4e94/skills/capital/modeling-counterparty-credit-exposure/SKILL.md
Attribution basis: Source repository record

Fields of work: Finance & Accounting, Sales
Roles: Accountant, Business Development, CFO / FP&A, Financial Analyst
Specialties: API
Tools: Financial Modeling Software
Country applicability: Country not specified
Classification basis: Source catalog labels
Instruction SHA-256: bf63993c10d9e091cd1426353f6b87dafebca6946fd12f6911b461865096abed
